Antiemetic Guideline Consistency and Incidence of Chemotherapy-Induced Nausea and Vomiting in US Community Oncology Practice: INSPIRE Study
Authors:
- 1 January 2014
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 10 (1) , 68-74
Abstract
Increased adherence to antiemetic guidelines could significantly reduce the incidence of chemotherapy-inducd nausea and vomiting after highly or moderately emetogenic chemotherapy.Keywords
This publication has 36 references indexed in Scilit:
- Prospective Validation of a Prediction Tool for Identifying Patients at High Risk for Chemotherapy-Induced Nausea and VomitingJournal of Supportive Oncology, 2012
- The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)Annals of Oncology, 2012
- Pragmatic randomised trials using routine electronic health records: putting them to the testBMJ, 2012
- Enhancing Patient-Provider Communication With the Electronic Self-Report Assessment for Cancer: A Randomized TrialJournal of Clinical Oncology, 2011
- Automated Symptom Alerts Reduce Postoperative Symptom Severity After Cancer Surgery: A Randomized Controlled Clinical TrialJournal of Clinical Oncology, 2011
- Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based studySupportive Care in Cancer, 2011
- Perception of healthcare providers versus patient reported incidence of chemotherapy-induced nausea and vomiting after the addition of NK-1 receptor antagonistsSupportive Care in Cancer, 2010
- Anticipatory nausea and vomitingSupportive Care in Cancer, 2010
- Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 2008
- Incidence of chemotherapy‐induced nausea and emesis after modern antiemeticsCancer, 2004